SAN DIEGO — Patients with Philadelphia chromosome-negative accelerated- or blast-phase myeloproliferative neoplasms who received allogeneic hematopoietic stem cells had a longer median OS than those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback